A new survey from Orlando Health reveals that over one-third of men (38%) would rather endure stressful situations, such as ...
News-Medical.Net on MSN
Over one-third of men would rather endure stressful situations than discuss prostate health
A new survey from Orlando Health reveals that over one-third of men (38%) would rather endure stressful situations, such as ...
Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, ...
40mon MSN
Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening
A European study has demonstrated a sustained long-term reduction in prostate cancer mortality through prostate-specific ...
Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) ("Actinium" or the "Company"), a leader in the development of differentiated targeted radiotherapies, announced today that new preclinical data for ...
Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, provides an overview of key 2025 milestones and outlook into 2026 in a ...
Everyday Health on MSN
Expert Q&A: Your Questions About the Cost of ADT for Advanced Prostate Cancer, Answered
Dr. Adam Weiner answers common questions about the costs of androgen deprivation therapy (ADT) for advanced prostate cancer and how to find help paying for it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback